CLINICAL_TRIALS
trial_result
· 2015-01-07
Clinical Trial Update: A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial results evaluating tocilizumab for reducing signs and symptoms in patients with rheumatoid arthritis are reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-01-07